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It has been previously documented that carotid intima-media thickness (cIMT) is a predictor of cardiovascular disease. The aim of
this study was to identify clinical parameters associated with an increased cIMT treated hypertensive women. Female patients (n =
116)withessentialhypertension,aged40–65years,wereincludedinthisstudy.Vascularultrasoundwasperformedandthepatients
were divided into two groups according to the values of cIMT (< or ≥0.9mm). Patients with greater cIMT presented signiﬁcantly
highersystolicbloodpressureandpulsepressure.SerumHDL-cholesterolwassigniﬁcantlylowerandCRPwassigniﬁcantlyhigher
in the same group. There was a signiﬁcant correlation between cIMT and age (r = 0.25, P = 0.007), systolic blood pressure
(r = 0.19, P = 0.009), pulse pressure (r = 0.30, P = 0.001), and LDL-cholesterol (r = 0.19, P = 0.043). cIMT was correlated
to CRP (r = 0.31, P = 0.007) and negatively correlated to HDL-cholesterol (r = 0.33, P = 0.001). In logistic regression, only
HDL-cholesterol, CRP, and pulse pressure were shown to be independent variables associated to increased cIMT. In conclusion,
pulse pressure, HDL-cholesterol, and CRP are variables correlated with cIMT in treated hypertensive women.
1.Introduction
Atherosclerosis and its complications are the main cause of
morbidityandmortalityintheWesternworld[1].Therefore,
anearlyacknowledgmentofhighcardiovascularriskpatients
is crucial to decrease the incidence of clinical events related
to atherosclerosis. This could be reached through the identi-
ﬁcation of markers of subclinical arterial disease [2].
It has been previously evidenced that carotid intima-
media thickness (IMT) is a noninvasive predictor of future
cardiovascular disease (CVD) [3]. The increase of carotid
IMT has been more commonly associated with development
of coronary heart disease and stroke [4, 5]. However, even
in asymptomatic subjects a slight increase of IMT may be
detected by high resolution ultrasonography and may rep-
resent a marker of subclinical atherosclerosis [6]. Recently,
Lorenz et al. reported a meta-analysis showing that the rela-
tive risk for stroke and myocardial infarction rises propor-
tionally to the increase of carotid IMT [7].
The identiﬁcation of risk factors associated with early
atherogenesis is important to stratify the individual risk and
to predict cardiovascular events [8]. It has been formerly
shown a close relationship between carotid IMT and tradi-
tional cardiovascular risk factors such as ageing, hyperten-
sion, obesity, dyslipidemia, and diabetes [9]. Moreover, the
presenceofatheroscleroticlesionsmayclassifyhighriskindi-
viduals who were not identiﬁed by the traditional risk factors
evaluation. Recently, Aguilar-Shea et al., including only
outpatients presenting low or intermediate cardiovascular
risk according to European SCORE function, demonstrated
that 18.4% of these patients were reclassiﬁed as high risk due
to increased carotid IMT. The authors concluded that the2 International Journal of Hypertension
measurement of carotid IMT may be an useful tool to identi-
fy asymptomatic subjects with subclinical atherosclerosis not
detected by the traditional risk factors evaluation [1].
The objective of this study was to identify clinical varia-
bles associated with subclinical atherosclerosis deﬁned by an
increased carotid IMT in treated hypertensive women.
2. Methods
2.1. Study Population. We studied hypertensive women re-
ferred to Outpatient Clinics of Hypertension and Associated
Metabolic Diseases at State University of Rio de Janeiro,
Brazil. Participants were 40 to 65 years old, with systolic
blood pressure ≥140mmHg, and/or diastolic blood pressure
≥90mmHg at two diﬀerent times and/or in antihypertensive
treatment.Patientswereexcludediftheyhadapasthistoryof
cardiovascular disease, clinically evident infection or inﬂam-
matory disease, diabetes mellitus, renal dysfunction with
estimatedglomerularﬁltrationrate<60mL/min,evidenceof
secondary hypertension, or using lipid-lowering medication
in the last year. Vascular ultrasound was performed and
the patients were divided into two groups according to the
values of carotid IMT (< or ≥0.9mm) [10]. The local Ethics
Committee previously approved the study protocol and all
participants gave written informed consent.
2.2.ClinicalEvaluation. Heightwasmeasuredonaclinicsta-
diometer. The body weight was assessed using a calibrated
scale, with participants using light clothes and no shoes. The
body mass index (BMI) was calculated as body weight (kg)
divided by square height (m2). The patients were classiﬁed
as eutrophic (18.5 to 24.9Kg/m2), overweight (25.0 to
29.9Kg/m2), or obese patients (30.0Kg/m2 or more) [11].
With a nonextensible tape measure, waist circumference
was measured at the midway between the lower rib and the
iliac crest. Waist circumference was considered increased for
women when the value was higher than 88cm [12]. Met-
abolic syndrome was deﬁned following the criteria from
the Third Report of The National Cholesterol Education
Program—Adult Treatment Panel III (NCEP-ATP III) [12].
Standardized questionnaires were used to obtain infor-
mation about physical activity, smoking history, medication
use, family history of cardiovascular disease, and duration
of hypertension. Systolic and diastolic blood pressure were
measured three times after a 5-minute rest, in a seated
position, using an electronic device (model HEM-705CP,
OMRON Healthcare Inc., IL, USA).
2.3.BiochemicalAssay. Venousbloodsamplesweretakenaft-
er the subject had fasted for 12 hours. The serum lipids (total
cholesterol, HDL-cholesterol, and triglycerides) were ana-
lyzed by colorimetry (Bioclin). The LDL-cholesterol was cal-
culated using the Friedewald formula [13] when triglyceride
value was less than 400mg/dL. High-sensitive C-reactive
protein (CRP) was determinated by turbidimetry using an
automatic analyzer (BioSystems A15).
2.4. Carotid Ultrasound. The patient was supine with slight
hyperextension and rotation of the neck in the direction
oppositetheprobe.Alineararraytransducerwithamultiple-
frequency (7 to 12MHz) attached to a high-resolution B-
mode ultrasound system was used to acquire images by a
single-sonographerblindtoclinicaldataofsubjects.Simulta-
neousECGwasrecordedtoassurethetimingofend-diastolic
images. Manual measurement of IMT was performed in the
common carotid artery, at both sides, in a region free of
plaquelocatedapproximately20mmfrombulb.Weanalysed
only patients without any atherosclerotic plaques. At least
three values were obtained in diﬀerent sites of this segment
and the mean value of six measurements (three from each
side) was used for analysis.
2.5. Statistical Analysis. Data were expressed as mean ± stan-
dard deviation or proportions when appropriate. Unpaired
Student’s t-test was used for comparison of continuous
variables, with a conﬁdence interval of 95% and P<
0.05 was considered statistically signiﬁcant. Menopause and
metabolic syndrome were considered as categorical variables
and were compared by Chi-squared test. The Pearson coefﬁ-
cient was obtained in the correlation tests between continu-
ousvariables.Ordinallogisticregressionwasusedtoevaluate
associations between increased carotid IMT and previously
correlated variables. All statistical analyses were performed
using SPSS statistical package (Version 18.0; Inc., Chicago,
IL, USA).
3. Results
One hundred eighteen patients were enrolled in the study,
but we excluded two patients for not having completed all
assessments, resulting in 116 patients included for analysis.
As expected, carotid IMT was signiﬁcantly greater in the
second group (0.74 ± 0.09 versus 1.03 ± 0.10mm, P<
0.001). Patients in the group with greater carotid IMT were
older and presented signiﬁcantly higher values of systolic
blood pressure and pulse pressure. The two groups had
mean BMI in the overweight range and increased values
of waist circumference. Regarding the biochemical proﬁle,
serumHDL-cholesterolwassigniﬁcantlylower,andCRPwas
signiﬁcantly higher in the group with greater carotid IMT.
Plasma glucose, creatinine, and other parameters of lipid
proﬁle were not diﬀerent between the two groups (Table 1).
The proportions of smoking (21 versus 10%, P>0.05),
physical activity (10 versus 18%, P>0.05) and menopause
(65.8 versus 78.0%, P>0.05) were similar between the two
groups. The most used antihypertensive medications were
diuretics (65.8 versus 65.7%, P>0.05) and angiotensin
converting enzyme inhibitors (64.5 versus 50.0%, P>0.05)
and there was no signiﬁcant diﬀerence between the two
groups.
There was a weak but signiﬁcant correlation between
c a r o t i dI M Ta n da g e( r = 0.25, P = 0.007), systolic blood
pressure (r = 0.19, P = 0,009), pulse pressure (r = 0.30,
P = 0.001), and LDL-cholesterol (r = 0.19, P = 0.043).
Carotid IMT was also positively correlated to CRP (r = 0.31,International Journal of Hypertension 3
Table 1: Clinical, anthropometric and biochemical characteristics
of both groups.
Parameter IMT ≤ 0.9
(n = 76)
IMT > 0.9
(n = 40) P-value
Age, years 50.8 ±6.65 3 .5 ± 7.1
∗ 0.044
BMI, kg/m2 28.9 ±4.52 9 .5 ±4.9 0.471
Waist, cm 98.4 ±11.29 9 .1 ±11.1 0.733
Systolic BP, mmHg 135 ±16 143 ± 21
∗ 0.020
Diastolic BP,
mmHg 85 ±11 83 ±9 0.253
Pulse pressure,
mmHg 49 ±11 60 ±17
∗∗∗ <0.001
Metabolic
Syndrome, n(%) 49(64.5) 33(82.5)∗ 0.043
eGFR, mL/min 75 ±14 74 ±15 0.863
Glucose, mg/dL 88 ±19 87 ±14 0.735
Creatinine, mg/dL 0.80 ±0.13 0.81 ±0.13 0.740
Total cholesterol,
mg/dL 209 ±54 255 ±64 0.157
HDL-cholesterol,
mg/dL 49 ±84 4 ±7∗∗ 0.004
LDL-cholesterol,
mg/dL 130 ±50 149 ±57 0.070
Triglycerides,
mg/dL 144 ±84 150 ±71 0.731
hsCRP, mg/L 2.31 ±1.21 3.05 ±1.34
∗ 0.016
IMT, mm 0.74 ±0.09 1.03 ±0.10∗∗∗ <0.001
Data expressed as mean ± SD or n(%) when indicated; IMT: intima-media
thickness; BMI: body mass index; BP: blood pressure; eGFR: estimated
glomerular ﬁltration rate; HDL: high density lipoprotein; LDL: low density
lipoprotein; hsCRP: high-sensitive C-reactive protein; ACE: angiotensin
converting enzyme; ARB: angiotensin receptor blocker. ∗P<0.05, ∗∗P<
0.01∗∗∗, P<0.001.
P = 0.007) and negatively correlated to HDL-cholesterol
(r = 0.33, P = 0.001) (Figures 1(a) and 1(b), resp.). To assess
which variables were independently correlated with IMT,
a logistic regression was performed with increased IMT as
dependentvariableandincludingage,menopause,metabolic
syndrome, systolic blood pressure, pulse pressure, HDL-
cholesterol and CRP as independent variables. In this model,
only HDL-cholesterol, CRP, and pulse pressure were shown
to be independent variables associated to increased carotid
IMT (Table 2).
4. Discussion
Carotid IMT has been related to cardiovascular events but
the link between this ﬁnding and clinical parameters in spe-
ciﬁc populations is not clear yet. In this study involving only
nondiabetic treated hypertensive women with no previous
cardiovascular event, carotid IMT was correlated with some
clinical factors, but only pulse pressure, HDL-cholesterol,
and CRP were considered independent parameters related to
carotid IMT.
Itiswellestablishedthatageisanimportantdeterminant
factor for carotid IMT value. In a population-based study,
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Figure 1: Correlation of carotid intima-media thickness (IMT)
with C-reactive protein (a) and with HDL-cholesterol (b).
Table 2: Logistic regression model for increased carotid intima-
media thickness (IMT > 0.9mm) as dependent variable.
Variables β Standard error P value
HDL-cholesterol 1.126 0.051 0.019
hsCRP 0.448 0.293 0.006
Pulse pressure 0.917 0.046 0.049
Variables included in the initial model: age, menopause, metabolic
syndrome, systolic blood pressure, pulse pressure, HDL (high density
lipoprotein)-cholesterol, and high-sensitive C-reactive protein (hsCRP).
Pastorius et al. evaluated 1448 healthy adults with no known
cardiovascular disease and demonstrated that age was an
independent predictor factor for increased carotid IMT [14].
Other longitudinal study including only elderly individuals
was also able to show the correlation between carotid IMT
values and age [15]. In contrast, age was not identiﬁed as a
clinical parameter independently associated to carotid IMT
in our study. This ﬁnding could be attributed to our sample
study composed only by middle-age hypertensive women
under drug therapy. In a recent study which included 136
subjects older than 80 years, carotid IMT was associated with
age in men but not in women [16].4 International Journal of Hypertension
Blood pressure levels have also been associated with
carotid IMT. In our study, all patients were in use of
antihypertensivedrugsandthemeandiastolicbloodpressure
levels were in the normal range. Systolic blood pressure was
higher in the group with subclinical atherosclerosis but only
pulse pressure was independently correlated with carotid
IMT. In agreement with this, some studies have already
reported association between increased carotid IMT and iso-
lated systolic hypertension [14, 17, 18]. Similarly, Zanchetti
et al. have also observed that ambulatory systolic blood
pressureandpulsepressureweresigniﬁcantlycorrelatedwith
carotid alterations even after adjustment for age, gender, and
smoking [19].
Several studies have already described the relationship
between subclinical atherosclerosis and obesity indicated
by elevated body mass index or waist circumference [20–
24]. However, this association is still controversial. Tokita
et al. carried out a cross-sectional study to examine the
association of obesity parameters with atherosclerosis in
obese patients. The authors concluded that the carotid
elasticity, but not IMT, was the only variable that reﬂects
visceral fat accumulation in those obese subjects [25]. In
the present study, there was no diﬀerence between the two
groups in relation to anthropometric parameters. Despite
an increased waist circumference in both groups, the mean
value was not statistically diﬀerent and there was no signiﬁ-
cant correlation with carotid IMT. Nevertheless, this ﬁnding
could be justiﬁed by the mean body mass index value in the
overweightrangeinbothgroupswithfewpatientspresenting
normal body mass index. Although metabolic syndrome
was signiﬁcantly more frequent in the group with increased
carotid IMT, this factor was not independently associated
with subclinical atherosclerosis in this study population after
logistic regression.
T h ep r o t e c t i v ee ﬀect of HDL-cholesterol is already well
debated and it is not clariﬁed yet. A recent meta-analysis
reported that the great majority of the included studies
observed an inverse association between HDL-cholesterol
and carotid atherosclerosis [26]. However, six longitudinal
studies in this systematic review demonstrated conﬂicting
results, with three reports showing no relationship and an
evidence of a weak association. Fan and Dwyer observed the
progression of carotid IMT in a cohort study that enrolled
500 individuals aged 40–60 years. In the beginning of this
study, carotid IMT was inversely associated with serum levels
of HDL-cholesterol in men and in women. Nevertheless,
after an adjustment for some potential confounding factors,
the progression of carotid IMT was negatively associated
with HDL-cholesterol in men, but directly in women. The
authors suggest that the antiatherogenic eﬀects of HDL-
cholesterol could be attenuated in middle-aged women [27].
The lack of association between carotid atherosclerosis and
HDL-cholesterol was also observed in a recent population-
basedstudy[14].Inthecurrentstudy, bothgroupspresented
low values of HDL-cholesterol in relation to those expected
for women, but signiﬁcantly lower in patients with increased
carotid IMT. This result indicates that even small increases
of HDL-cholesterol could be protective against subclinical
atherosclerosis in hypertensive women. Other plasma lipids
were not diﬀerent between the two groups in the current
study. On the other hand, the same authors have previously
shown a relationship between carotid IMT and serum
triglycerides, total cholesterol and LDL-cholesterol [28, 29].
Elevated CRP has been considered a predictor of car-
diovascular events. A clinical history carefully obtained and
a complete physical examination are needed in order to
rule out an obvious cause for increased CRP [30]. In the
currentstudy,patientspresentinginfectionsorinﬂammatory
diseases were excluded to avoid interpretation errors on CRP
analysis. High-sensitive CRP levels were signiﬁcantly higher
in the group with higher carotid IMT values. However,
even in the group with lower carotid IMT, CRP levels
corresponded to intermediate cardiovascular risk. A possible
explanation for this ﬁnding is because all patients were
hypertensive with increased abdominal circumference which
is also related to raised CRP levels [31, 32]. Increased CRP
levels without intima-media carotid artery thickening may
suggest a possible role as a risk marker of cardiovascular
disease and a mediator in atherogenesis due to its eﬀects in
endothelial cells as previously reported [6]. In addition, CRP
levels were independently associated with increased IMT as
it was previously found by other studies, [33, 34] including
F r a m i n g h a mc o h o r t[ 35]. Nevertheless, these ﬁndings were
notconﬁrmedbyallstudies[36,37].Indeed,therelationship
between carotid atherosclerosis and CRP levels were not
signiﬁcant after adjustment for other risk factors in some
studies [38, 39].
5. Conclusion
We concluded that pulse pressure, HDL-cholesterol, and
high-sensitive CRP are variables correlated with carotid IMT
in treated hypertensive women with no diabetes or previous
cardiovascular events. Therefore, these parameters should be
carefully followed in this population as potential markers
of subclinical atherosclerosis. Noticeably, further studies are
needed to establish the prognostic value of clinical and
biochemical factors associated with increased carotid IMT in
treated hypertensive patients.
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